Study Title and Description
Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
Key Questions Addressed
|3||KQ3a. What is the comparative effectiveness of nonpharmacologic therapy versus sham treatment, waitlist, usual care, attention control, and no treatment after followup at the following intervals: < 1 day; 1 day to <1 week; 1 week to <2 weeks; 2 weeks to 4 weeks? KQ3b. What is the comparative effectiveness of nonpharmacologic treatments (e.g. exercise, cognitive behavioral therapy, acupuncture, biofeedback, noninvasive neuromodulation devices) for outcomes related to pain, function, pain relief satisfaction, and quality of life? KQ3c. How does effectiveness of nonpharmacologic therapy vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities? KQ3d. How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of treatment used; (4) the frequency of therapy; (5) the duration of therapy?|
Primary Publication Information
|Title||Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.|
|Author||Chou DE., Shnayderman Yugrakh M., Winegarner D., Rowe V., Kuruvilla D., Schoenen J.|
|Country||1 Department of Neurology, Columbia University Medical Center, New York, NY, USA.|
Pubmed ID: 30449151
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Question 3
|Question... Follow Up||Answer||Follow-up Answer|
Results & Comparisons
No Results found.